RxDoctor Payments Data

Natalie Driscoll, NP

Nurse Practitioner · Middletown, RINPI 1982014502

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 295 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 13.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,390 and has fallen 55.1% since, to $1,074 in 2025. Among nurse practitioner clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,975in general payments, 2019–2025

Across 295 payments — averaging $20.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$827
  • Pfizer$679
  • LEO Pharma Inc.$616
  • Amgen$610
  • Novartis$547
  • Sanofi$518
  • plus $2K from 20 others

What the payments were for

  • Food & beverage$5,975100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,975 in reported general payments places this provider in the 95th percentile of 396 nurse practitioner providers in Rhode Island.

See all nurse practitioner providers in Rhode Island

Medicare billing

Part B allowed, 2024
$98,369
Medicare patients
440
Services billed
2,114

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa14$305,473
Cosentyx Sensoready (2 Pens)Secukinumab11$94,864
Ketoconazole403$7,340
Metronidazole97$4,487
Clobetasol Propionate70$3,763
Tacrolimus18$2,126
Ciclopirox44$1,499
Doxycycline Monohydrate51$1,219
Fluocinonide28$1,022
Clindamycin Phosphate29$1,007
Triamcinolone Acetonide85$980
Fluconazole70$966
Doxycycline Hyclate24$852
Nystatin44$819
Betamethasone Dipropionate23$780

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Middletown

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →